Intriguingly, we found that PIC significantly improved the tumor response and animal survival when combined with RT + anti-CTLA-4, compared to RT + anti-CTLA-4 alone (Fig. 5b–d and Supplementary Table 6). Here, CTLA4 is linked to neoplasm.